TY - JOUR
T1 - Evidence-based guidelines for treatment of cervical cancer in Japan
T2 - Japan Society of Gynecologic Oncology (JSGO) 2007 edition
AU - Nagase, Satoru
AU - Inoue, Yoshiki
AU - Umesaki, Naohiko
AU - Aoki, Daisuke
AU - Ueda, Masatsugu
AU - Sakamoto, Hideki
AU - Kobayashi, Shigemitsu
AU - Kitagawa, Ryo
AU - Toita, Takafumi
AU - Nagao, Shoji
AU - Hasegawa, Kiyoshi
AU - Fukasawa, Ichio
AU - Fujiwara, Keiichi
AU - Watanabe, Yoh
AU - Ito, Kiyoshi
AU - Niikura, Hitoshi
AU - Iwasaka, Tsuyoshi
AU - Ochiai, Kazunori
AU - Katabuchi, Hidetaka
AU - Kamura, Toshiharu
AU - Konishi, Ikuo
AU - Sakuragi, Noriaki
AU - Tanaka, Tadao
AU - Hirai, Yasuo
AU - Hiramatsu, Yuji
AU - Mukai, Makio
AU - Yoshikawa, Hiroyuki
AU - Takano, Tadao
AU - Yoshinaga, Kosuke
AU - Otsuki, Takeo
AU - Sakuma, Michiko
AU - Inaba, Noriyuki
AU - Udagawa, Yasuhiro
AU - Yaegashi, Nobuo
N1 - Funding Information:
K. Fujiwara has employment with Zeria Pharmaceuticals and received honoraria from Bristol-Myers Squibb, Sanofi Aventis, Yakult Honsha, Janseen Pharmaceutical and Zeria Pharmaceuticals. K. Fujiwara also received research funding from Sanofi Aventis, Kaken Pharmaceutical, and Nippon Kayaku. K. Ochiai received honoraria from Taiho Pharmaceutical and research funding from Bristol-Myers Squibb and Chugai Pharmaceutical. No other author has a conflict of interest.
PY - 2010/4
Y1 - 2010/4
N2 - Clinical practice guidelines for gynecologic cancers have been published by the National Comprehensive Cancer Network and the National Cancer Institute. Whereas these guidelines form the basis for the standard of care for gynecologic malignancies in the United States, it has proven difficult to institute them in Japan due to differences in patient characteristics, health-care delivery systems, and insurance programs. Therefore, evidence-based guidelines for treating cervical cancer specifically in Japan have been under development. The Guidelines Formulation Committee and Evaluation Committee were independently established within the Committee for Treatment Guidelines for Cervical Cancer. Opinions from within and outside the Japan Society of Gynecologic Oncology (JSGO) were incorporated into the final draft, and the guidelines were published after approval by the JSGO. These guidelines are composed of ten chapters and comprise three algorithms. Each chapter consists of a clinical question, recommendations, background, objectives, explanations, and references. The objective of these guidelines is to clearly delineate the standard of care for cervical cancer treatment in Japan in order to ensure equitable care for all Japanese women diagnosed with cervical cancer.
AB - Clinical practice guidelines for gynecologic cancers have been published by the National Comprehensive Cancer Network and the National Cancer Institute. Whereas these guidelines form the basis for the standard of care for gynecologic malignancies in the United States, it has proven difficult to institute them in Japan due to differences in patient characteristics, health-care delivery systems, and insurance programs. Therefore, evidence-based guidelines for treating cervical cancer specifically in Japan have been under development. The Guidelines Formulation Committee and Evaluation Committee were independently established within the Committee for Treatment Guidelines for Cervical Cancer. Opinions from within and outside the Japan Society of Gynecologic Oncology (JSGO) were incorporated into the final draft, and the guidelines were published after approval by the JSGO. These guidelines are composed of ten chapters and comprise three algorithms. Each chapter consists of a clinical question, recommendations, background, objectives, explanations, and references. The objective of these guidelines is to clearly delineate the standard of care for cervical cancer treatment in Japan in order to ensure equitable care for all Japanese women diagnosed with cervical cancer.
KW - Chemotherapy
KW - Clinical practice guidelines
KW - Irradiation
KW - Surgery
KW - Uterine cervical cancer
UR - http://www.scopus.com/inward/record.url?scp=77950932931&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77950932931&partnerID=8YFLogxK
U2 - 10.1007/s10147-010-0061-x
DO - 10.1007/s10147-010-0061-x
M3 - Review article
C2 - 20333431
AN - SCOPUS:77950932931
SN - 1341-9625
VL - 15
SP - 117
EP - 124
JO - International Journal of Clinical Oncology
JF - International Journal of Clinical Oncology
IS - 2
ER -